OMERS ADMINISTRATION Corp Purchases 509 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

OMERS ADMINISTRATION Corp boosted its stake in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 20.5% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 2,987 shares of the biotechnology company's stock after buying an additional 509 shares during the period. OMERS ADMINISTRATION Corp's holdings in Axon Enterprise were worth $1,775,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also bought and sold shares of the company. Artemis Investment Management LLP grew its stake in Axon Enterprise by 21.4% in the 4th quarter. Artemis Investment Management LLP now owns 95,113 shares of the biotechnology company's stock valued at $56,528,000 after buying an additional 16,792 shares during the last quarter. Decker Retirement Planning Inc. acquired a new position in Axon Enterprise in the 4th quarter valued at about $2,985,000. Perigon Wealth Management LLC acquired a new position in Axon Enterprise in the 4th quarter valued at about $488,000. Hennion & Walsh Asset Management Inc. boosted its holdings in Axon Enterprise by 26.8% in the 4th quarter. Hennion & Walsh Asset Management Inc. now owns 7,169 shares of the biotechnology company's stock valued at $4,261,000 after purchasing an additional 1,517 shares during the period. Finally, Geneos Wealth Management Inc. boosted its holdings in Axon Enterprise by 630.0% in the 4th quarter. Geneos Wealth Management Inc. now owns 1,847 shares of the biotechnology company's stock valued at $1,098,000 after purchasing an additional 1,594 shares during the period. Institutional investors and hedge funds own 79.08% of the company's stock.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, Director Jeri Williams sold 307 shares of the company's stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the transaction, the director now directly owns 1,627 shares in the company, valued at approximately $899,275.44. This represents a 15.87% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Patrick W. Smith sold 10,000 shares of the company's stock in a transaction that occurred on Monday, April 21st. The shares were sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the completion of the transaction, the chief executive officer now owns 3,063,982 shares of the company's stock, valued at approximately $1,657,583,622.18. This trade represents a 0.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 23,764 shares of company stock valued at $14,856,635 in the last quarter. Insiders own 4.40% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on AXON shares. JMP Securities reissued an "outperform" rating on shares of Axon Enterprise in a report on Tuesday, February 4th. The Goldman Sachs Group boosted their price objective on shares of Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a report on Wednesday. Barclays boosted their price objective on shares of Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a report on Friday, May 9th. Northcoast Research downgraded shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a report on Wednesday, February 19th. Finally, Needham & Company LLC boosted their price objective on shares of Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a report on Thursday, May 8th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and ten have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $652.73.

Axon Enterprise Price Performance

Shares of Axon Enterprise stock traded up $4.79 on Friday, reaching $733.18. 419,101 shares of the stock were exchanged, compared to its average volume of 759,084. The firm's 50 day moving average is $584.61 and its 200-day moving average is $595.70. Axon Enterprise, Inc. has a one year low of $273.52 and a one year high of $735.68. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The firm has a market cap of $57.08 billion, a PE ratio of 189.45, a P/E/G ratio of 5.17 and a beta of 1.24.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 EPS for the quarter, beating the consensus estimate of $1.34 by $0.07. The business had revenue of $603.63 million during the quarter, compared to the consensus estimate of $585.67 million. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. The firm's revenue was up 31.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.15 EPS. As a group, analysts anticipate that Axon Enterprise, Inc. will post 5.8 EPS for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.